Finance

Immunotherapy company announces IPO on Nasdaq

Published in Biotech Business Week, November 24th, 2003

Genitope Corp. (GTOP) announced the initial public offering of 3,700,000 shares of its common stock at $9.00 per share on the Nasdaq National Market under the trading symbol GTOP.

Genitope has granted the underwriters the right to purchase up to an additional 555,000 shares of common stock to cover over allotments, if any. All of such shares are being offered by Genitope Corp.

WR Hambrecht + Co. is acting as the lead underwriter of the offering. Punk, Ziegel & Co. and Brean Murray & Co., Inc., are acting as comanagers.

Genitope Corp. is a biotechnology company focused on the research and development of novel immunotherapies for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2003-11-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry